A randomized clinical trial published in JAMA Internal Medicine found that weekly extended-release buprenorphine during pregnancy was associated with higher rates of abstinence from illicit opioids than daily sublingual buprenorphine among pregnant women with opioid use disorder.

Friends Research Hub conducted two recent JCOIN 1.0 studies that offer complementary perspectives on how extended-release buprenorphine (XR-B) can be initiated and sustained across incarceration and reentry.

This SAMHSA advisory explores innovative, community-driven solutions to close these gaps and improve access to life-saving behavioral health services. One promising way to improve behavioral health care in areas with few services is to add more community health workers and peer support specialists.